BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21804239)

  • 1. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
    Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
    Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
    AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sorghum starch as a tablet disintegrant and binder.
    Deshpande AV; Panya LB
    J Pharm Pharmacol; 1987 Jun; 39(6):495-6. PubMed ID: 2886614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.
    Juan C; Gallo L; Gonzalez Vidal N
    AAPS PharmSciTech; 2024 Apr; 25(4):79. PubMed ID: 38589718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the fundamental effects of binders on pharmaceutical tablet performance.
    Joneja SK; Harcum WW; Skinner GW; Barnum PE; Guo JH
    Drug Dev Ind Pharm; 1999 Oct; 25(10):1129-35. PubMed ID: 10529894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y; Kojima M; Ando S; Nakagami H
    Int J Pharm; 2008 May; 355(1-2):87-92. PubMed ID: 18182258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
    Que L; Wu W; Cheng X; Hu T
    Pharm Dev Technol; 2006; 11(3):295-301. PubMed ID: 16895840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of fluidized hot-melt granulation (FHMG) for the preparation of granules for tableting; properties of granules and tablets prepared by FHMG.
    Kidokoro M; Haramiishi Y; Sagasaki S; Shimizu T; Yamamoto Y
    Drug Dev Ind Pharm; 2002 Jan; 28(1):67-76. PubMed ID: 11858526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T
    Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
    Tarimci N; Celebi N
    Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based nanoscopic and molecular framework for excipient functionality in compressed orally disintegrating tablets.
    Al-Khattawi A; Alyami H; Townsend B; Ma X; Mohammed AR
    PLoS One; 2014; 9(7):e101369. PubMed ID: 25025427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants.
    Alebiowu G; Itiola OA
    Acta Pharm; 2003 Dec; 53(4):313-20. PubMed ID: 14769238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA; Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.